Company Analysis

Phibro Animal Health Corporation (PAHC)

Nasdaq: PAHC · Pharmaceutical Preparations · Teaneck, NJ · filing with the SEC since 1998
Grade6.4
◀ Past 8.0● Present 6.4▶ Future 4.7

Who runs Phibro Animal Health Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Bendheim Daniel M
President and CEO. First filing Apr 2014, latest Aug 10, 2026, 10 filings in all.
Officers reporting now
8
of 10 people with a filing in the last fifteen months
Directors reporting now
2
19 people on the record since 2014
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
David GlennChief Financial OfficerFeb 2024Sep 17, 2026none
Miller Larry LeeChief Operating OfficerApr 2014Sep 17, 2026none
Bendheim Daniel MPresident and CEOApr 2014Aug 10, 2026none
Bendheim JackExecutive ChairmanApr 2014Aug 10, 202661 · $13.8M
Escudero Lisa AnnSenior Vice President, Human Resources.Mar 2017Aug 10, 2026none
Weinstein JudithSenior Vice President, General Counsel and Corporate Secretary.Jul 2023Aug 10, 2026none
Rodriguez PatrickVP Finance and TreasurerJan 2026Aug 10, 2026none
Andolino AnthonyVice President Finance and Treasurer. Exhibit List - Exhibit 24.1 Power of AttorneyMar 2018Aug 19, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bendheim JonathandirectorSep 2018Aug 10, 2026none
Corcoran E ThomasdirectorApr 2014Jun 2, 2026none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bfi Co., LLC10% ownerApr 2014Aug 10, 202657 · $17.1M
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton PAHC · research, not advice